By generating a specific mutation in lab mice, researchers determined that a protein domain in an enzyme called adenosine deaminase 1 p150 is necessary for binding and editing certain RNA molecules. Mutant mice showed inhibited growth after birth, as well as abnormally developed organs. Interestingly, their brains showed characteristics similar to encephalopathy seen in humans suffering from Aicardi-Goutières syndrome (AGS), a genetic inflammatory disorder. This work could help revolutionize treatment methods for AGS.
from Top Health News -- ScienceDaily https://ift.tt/3Ckha2a
Subscribe to:
Post Comments (Atom)
Omicron has cast a shadow of uncertainty on growth outlook: IndiGo CEO
However, the airline is stronger now when compared to situation in 2020 during the first wave of the pandemic, says Ronojoy Dutta from Com...
-
It is looking at raising a debt of Rs 450 crore for the Eluru project and Rs 400 crore for the Bengaluru project, the official added from ...
-
With 73,642 new daily recoveries, the most so far, India's recovery rate has improved to 77.32%, while death rate has come down to 1.72%...
-
Modi said political stability through a massive mandate for his government alongside predictable policy provides a unique opportunity for In...
No comments:
Post a Comment